Phospho-HMG17 (Ser29) Antibody - #AF8065
Product: | Phospho-HMG17 (Ser29) Antibody |
Catalog: | AF8065 |
Description: | Rabbit polyclonal antibody to Phospho-HMG17 (Ser29) |
Application: | WB IHC |
Reactivity: | Human, Mouse, Rat |
Prediction: | Pig, Zebrafish, Bovine, Dog, Chicken, Xenopus |
Mol.Wt.: | 9 kDa; 9kD(Calculated). |
Uniprot: | P05204 |
RRID: | AB_2840128 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# AF8065, RRID:AB_2840128.
Fold/Unfold
High mobility group (nonhistone chromosomal) protein 17; high mobility group nucleosomal binding domain 2; High mobility group nucleosome-binding domain-containing protein 2; High mobility group protein N2; HMG17; HMGN2; HMGN2_HUMAN; MGC5629; Non histone chromosomal protein HMG 17; Non-histone chromosomal protein HMG-17; Nonhistone chromosomal protein HMG 17; nonhistone chromosomal protein hmg-17;
Immunogens
- P05204 HMGN2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MPKRKAEGDAKGDKAKVKDEPQRRSARLSAKPAPPKPEPKPKKAPAKKGEKVPKGKKGKADAGKEGNNPAENGDAKTDQAQKAEGAGDAK
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P05204 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
M1 | Acetylation | Uniprot | |
K3 | Acetylation | Uniprot | |
K5 | Acetylation | Uniprot | |
K11 | Acetylation | Uniprot | |
K14 | Acetylation | Uniprot | |
K18 | Sumoylation | Uniprot | |
S25 | Phosphorylation | Q96GD4 (AURKB) , P17252 (PRKCA) , P17612 (PRKACA) , P51812 (RPS6KA3) | Uniprot |
S29 | Phosphorylation | P17252 (PRKCA) , Q96GD4 (AURKB) , P51812 (RPS6KA3) , P17612 (PRKACA) | Uniprot |
K31 | Acetylation | Uniprot | |
K31 | Ubiquitination | Uniprot | |
K36 | Acetylation | Uniprot | |
K36 | Sumoylation | Uniprot | |
K36 | Ubiquitination | Uniprot | |
K40 | Acetylation | Uniprot | |
K40 | Ubiquitination | Uniprot | |
K47 | Ubiquitination | Uniprot | |
K48 | Ubiquitination | Uniprot | |
K51 | Ubiquitination | Uniprot | |
K54 | Acetylation | Uniprot | |
K56 | Acetylation | Uniprot | |
K57 | Acetylation | Uniprot | |
K59 | Acetylation | Uniprot | |
K64 | Acetylation | Uniprot | |
K64 | Ubiquitination | Uniprot | |
K76 | Acetylation | Uniprot | |
K76 | Ubiquitination | Uniprot | |
K82 | Acetylation | Uniprot | |
K82 | Sumoylation | Uniprot | |
K82 | Ubiquitination | Uniprot | |
K90 | Acetylation | Uniprot |
Research Backgrounds
Binds to the inner side of the nucleosomal DNA thus altering the interaction between the DNA and the histone octamer. May be involved in the process which maintains transcribable genes in a unique chromatin conformation (By similarity).
Phosphorylation favors cytoplasmic localization.
Nucleus. Cytoplasm.
Note: Cytoplasmic enrichment upon phosphorylation.
Belongs to the HMGN family.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.